Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

EU pauses tariffs against US for 90 days

(Sharecast News) - The European Union said it was pausing new tariffs against the US for 90 days, opening the door for talks with US President with Donald Trump.

The move followed Trump's decision last night to pause tariffs on countries who had not retaliated against his initial raft trade levies for 90 days while reducing them to 10%.

"We took note of the announcement by President Trump. We want to give negotiations a chance," said European Commission Ursula von der Leyen.

"While finalising the adoption of the EU countermeasures that saw strong support from our Member States, we will put them on hold for 90 days."

"If negotiations are not satisfactory, our countermeasures will kick in. Preparatory work on further countermeasures continues. As I have said before, all options remain on the table."

The 27-nation bloc on Wednesday agreed to impose retaliatory tariffs on €21bn of US goods, targeting farm produce and products from states held by Trump's Republican party with the first duties to collected from April 15.

At the time it said US tariffs were "unjustified and damaging, causing economic harm to both sides, as well as the global economy".

"These countermeasures can be suspended at any time, should the US agree to a fair and balanced negotiated outcome."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.